Supplements That Help With Ozempic (Semaglutide) Nausea: What the Evidence Actually Shows

What the Ozempic label reports

The Ozempic label lists nausea, vomiting, diarrhea, abdominal pain and constipation as the most common adverse reactions, each reported in 5% or more of treated patients [1]. In the label's pooled placebo-controlled trials (262 people on placebo, 260 on 0.5 mg and 261 on 1 mg, mean exposure 32.9 weeks), nausea occurred in 6.1% on placebo, 15.8% on 0.5 mg and 20.3% on 1 mg; vomiting in 2.3%, 5% and 9.2%; and diarrhea in 1.9%, 8.5% and 8.8% [1]. Any gastrointestinal reaction was reported in 15.3%, 32.7% and 36.4% respectively, and 0.4%, 3.1% and 3.8% stopped treatment for a GI reason [1].

The label states that the majority of reports of nausea, vomiting and diarrhea occurred during dose escalation [1]. The injection schedule starts at 0.25 mg weekly for 4 weeks, then moves to 0.5 mg, with each further increase (to 1 mg, then 2 mg) made only after at least 4 weeks on the current dose [1].

In a 40-week trial of 959 patients comparing 2 mg with 1 mg, GI reactions were reported in 34% on 2 mg and 30.8% on 1 mg, with no new safety signals [1]. Severe GI reactions were more frequent on Ozempic than placebo: 0% on placebo, 0.4% on 0.5 mg and 0.8% on 1 mg [1].

The label also says Ozempic is not recommended in people with severe gastroparesis. It reports postmarketing cases of acute kidney injury, most of them in people who had GI reactions such as nausea, vomiting or diarrhea leading to dehydration, and says to monitor renal function in patients reporting reactions that could lead to volume depletion, especially during initiation and dose increases [1]. It also says Ozempic delays gastric emptying and can affect the absorption of oral medicines taken at the same time [1].

What the supplement studies were done in

The studies below tested ginger, vitamin B6, peppermint oil and probiotics in pregnancy nausea, chemotherapy nausea, nausea in the minutes after heart surgery, irritable bowel syndrome and functional dyspepsia. The CBD meta-analysis measured side effects rather than symptom relief.

Ginger

Two reviews cover the ginger evidence. The first describes ginger rhizome as a traditional remedy for gastrointestinal complaints, with gingerols and shogaols as the pungent active compounds, and reports that preclinical and clinical studies have assessed ginger as effective and safe for nausea and vomiting of pregnancy and as an adjuvant for chemotherapy-induced nausea and vomiting [2]. The second sets out the proposed mechanisms: gingerol and shogaol compounds act as antagonists at 5-HT3, substance P and acetylcholine receptors, have anti-inflammatory properties, and modulate gastrointestinal motility and the rate of gastric emptying [3]. Both reviews concern pregnancy or chemotherapy nausea, so they do not tell us whether ginger helps nausea from Ozempic.

Vitamin B6

A randomized, double-blind trial of vitamin B6 (pyridoxine) for nausea and vomiting of pregnancy was completed by 59 women: 31 took 25 mg every 8 hours for 72 hours and 28 took placebo [4]. Among the 22 women who began with severe nausea (a score above 7 on a 10 cm visual analogue scale), the nausea score fell by 4.3 points with vitamin B6 and 1.8 points with placebo (P<0.01); by day 3, 8 of 31 women on vitamin B6 were still vomiting versus 15 of 28 on placebo (P<0.05) [4]. There was no significant difference in women whose nausea was mild to moderate, or in the group as a whole [4].

Peppermint oil

A report in a nursing journal followed 123 patients who consented after cardiac surgery; 34 of them (28%) had postoperative nausea and were offered a nasal inhaler containing peppermint oil [5]. Among those 34 patients, the mean nausea rating was 3.29 on a 0 to 5 scale before use and 1.44 two minutes later (paired t-test P=0.000); the report describes no placebo or comparison group, so it cannot show the oil caused the drop [5].

For oral peppermint oil, a meta-analysis of 12 randomized trials in 835 adults with irritable bowel syndrome found peppermint oil beat placebo on global symptoms (risk ratio 2.39, 95% CI 1.93 to 2.97) and on abdominal pain (risk ratio 1.78, 95% CI 1.43 to 2.20) [7]. Its primary outcomes were global symptoms and abdominal pain, not nausea, and adverse events were reported by 9.3% on peppermint oil and 6.1% on placebo (not a significant difference) [7].

Probiotics

A systematic review of prebiotics, probiotics and synbiotics in functional dyspepsia found 5 eligible randomized trials; pooling them gave a risk ratio of 1.15 (95% CI 1.01 to 1.30) for symptom improvement [6]. The authors concluded that the treatments seemed effective but that the most beneficial species and strains remain unclear, that probiotics used alone failed to improve dyspepsia symptoms, and that further evidence is required [6].

CBD

The randomized evidence on CBD is about adverse effects rather than nausea. A meta-analysis of 12 placebo-controlled trials with 803 participants found CBD was associated with more withdrawals for any reason (odds ratio 2.61, 95% CI 1.38 to 4.96) and, after childhood epilepsy trials were excluded, more diarrhea (odds ratio 5.03, 95% CI 1.44 to 17.61) [8].

What the label describes instead

For GI reactions, the Ozempic label describes a slow dose schedule (0.25 mg for 4 weeks, then 0.5 mg, with later increases only after at least 4 weeks on the current dose) and a warning about dehydration and kidney injury when nausea, vomiting or diarrhea cause fluid loss [1]. It names no supplement for nausea [1].